554 related articles for article (PubMed ID: 22874761)
1. Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth.
Li H; Yang W; Mendes F; Amaral MD; Sheppard DN
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1176-86. PubMed ID: 22874761
[TBL] [Abstract][Full Text] [Related]
2. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
Li H; Findlay IA; Sheppard DN
Kidney Int; 2004 Nov; 66(5):1926-38. PubMed ID: 15496164
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
Xu N; Glockner JF; Rossetti S; Babovich-Vuksanovic D; Harris PC; Torres VE
J Nephrol; 2006; 19(4):529-34. PubMed ID: 17048214
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
Stanton BA
Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
[TBL] [Abstract][Full Text] [Related]
6. Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
Awatade NT; Uliyakina I; Farinha CM; Clarke LA; Mendes K; Solé A; Pastor J; Ramos MM; Amaral MD
EBioMedicine; 2015; 2(2):147-53. PubMed ID: 26137539
[TBL] [Abstract][Full Text] [Related]
7. A chemical corrector modifies the channel function of F508del-CFTR.
Kim Chiaw P; Wellhauser L; Huan LJ; Ramjeesingh M; Bear CE
Mol Pharmacol; 2010 Sep; 78(3):411-8. PubMed ID: 20501743
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
[TBL] [Abstract][Full Text] [Related]
9. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
Borthwick LA; Riemen C; Goddard C; Colledge WH; Mehta A; Gerke V; Muimo R
Cell Signal; 2008 Jun; 20(6):1073-83. PubMed ID: 18346874
[TBL] [Abstract][Full Text] [Related]
10. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
[TBL] [Abstract][Full Text] [Related]
11. Basolateral chloride transporters in autosomal dominant polycystic kidney disease.
Lebeau C; Hanaoka K; Moore-Hoon ML; Guggino WB; Beauwens R; Devuyst O
Pflugers Arch; 2002 Sep; 444(6):722-31. PubMed ID: 12355171
[TBL] [Abstract][Full Text] [Related]
12. Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue.
Trinh NT; Bardou O; Privé A; Maillé E; Adam D; Lingée S; Ferraro P; Desrosiers MY; Coraux C; Brochiero E
Eur Respir J; 2012 Dec; 40(6):1390-400. PubMed ID: 22496330
[TBL] [Abstract][Full Text] [Related]
13. Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells.
Antigny F; Norez C; Cantereau A; Becq F; Vandebrouck C
Respir Res; 2008 Oct; 9(1):70. PubMed ID: 18973672
[TBL] [Abstract][Full Text] [Related]
14. The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.
Le Henaff C; Gimenez A; Haÿ E; Marty C; Marie P; Jacquot J
Am J Pathol; 2012 May; 180(5):2068-75. PubMed ID: 22449949
[TBL] [Abstract][Full Text] [Related]
15. F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis.
Martins JR; Kongsuphol P; Sammels E; Dahimène S; Aldehni F; Clarke LA; Schreiber R; de Smedt H; Amaral MD; Kunzelmann K
Biochim Biophys Acta; 2011 Nov; 1812(11):1385-92. PubMed ID: 21907281
[TBL] [Abstract][Full Text] [Related]
16. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a novel polarized MDCK epithelial cellular model for CFTR studies.
Mendes F; Wakefield J; Bachhuber T; Barroso M; Bebok Z; Penque D; Kunzelmann K; Amaral MD
Cell Physiol Biochem; 2005; 16(4-6):281-90. PubMed ID: 16301828
[TBL] [Abstract][Full Text] [Related]
18. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
[TBL] [Abstract][Full Text] [Related]
19. Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.
Cai Z; Palmai-Pallag T; Khuituan P; Mutolo MJ; Boinot C; Liu B; Scott-Ward TS; Callebaut I; Harris A; Sheppard DN
J Physiol; 2015 Jun; 593(11):2427-46. PubMed ID: 25763566
[TBL] [Abstract][Full Text] [Related]
20. The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.
Pasyk S; Molinski S; Ahmadi S; Ramjeesingh M; Huan LJ; Chin S; Du K; Yeger H; Taylor P; Moran MF; Bear CE
Proteomics; 2015 Jan; 15(2-3):447-61. PubMed ID: 25330774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]